Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
This study has been completed.
Sponsor:
Ablynx
Information provided by (Responsible Party):
Ablynx
ClinicalTrials.gov Identifier:
NCT01020383
First received: November 23, 2009
Last updated: July 11, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2012 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |